GB967610A - Sustained release medicament formulations - Google Patents

Sustained release medicament formulations

Info

Publication number
GB967610A
GB967610A GB38360/62A GB3836062A GB967610A GB 967610 A GB967610 A GB 967610A GB 38360/62 A GB38360/62 A GB 38360/62A GB 3836062 A GB3836062 A GB 3836062A GB 967610 A GB967610 A GB 967610A
Authority
GB
United Kingdom
Prior art keywords
polyoxyethylene glycol
medicament
tablets
esters
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38360/62A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB967610A publication Critical patent/GB967610A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB38360/62A 1961-10-20 1962-10-10 Sustained release medicament formulations Expired GB967610A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14642261A 1961-10-20 1961-10-20

Publications (1)

Publication Number Publication Date
GB967610A true GB967610A (en) 1964-08-26

Family

ID=22517286

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38360/62A Expired GB967610A (en) 1961-10-20 1962-10-10 Sustained release medicament formulations

Country Status (6)

Country Link
BE (1) BE623704A (fr)
DE (1) DE1219176B (fr)
ES (1) ES281704A1 (fr)
FR (1) FR2172M (fr)
GB (1) GB967610A (fr)
MY (1) MY6600083A (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2254109A1 (de) * 1971-11-17 1973-05-24 Colgate Palmolive Co Koerniges material, insbesondere zur verwendung in zahnreinigungsmitteln, sowie verfahren zu dessen herstellung
US4289795A (en) * 1975-11-17 1981-09-15 Aktiebolaget Hassle Method for preparing preparations having controlled release of an active component
EP0177368A2 (fr) * 1984-10-05 1986-04-09 Warner-Lambert Company Système pour la libération d'un médicament et procédé pour sa préparation
EP0190255A1 (fr) * 1984-07-23 1986-08-13 Zetachron Inc Matrice erodable pour compositions bioactives a degagement soutenu.
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217071A1 (de) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2254109A1 (de) * 1971-11-17 1973-05-24 Colgate Palmolive Co Koerniges material, insbesondere zur verwendung in zahnreinigungsmitteln, sowie verfahren zu dessen herstellung
US4289795A (en) * 1975-11-17 1981-09-15 Aktiebolaget Hassle Method for preparing preparations having controlled release of an active component
US4341759A (en) * 1975-11-17 1982-07-27 Aktiebolaget Hassle Granule having controlled release properties
EP0190255A1 (fr) * 1984-07-23 1986-08-13 Zetachron Inc Matrice erodable pour compositions bioactives a degagement soutenu.
EP0190255A4 (fr) * 1984-07-23 1987-10-20 Zetachron Inc Matrice erodable pour compositions bioactives a degagement soutenu.
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
EP0177368A2 (fr) * 1984-10-05 1986-04-09 Warner-Lambert Company Système pour la libération d'un médicament et procédé pour sa préparation
EP0177368A3 (fr) * 1984-10-05 1987-12-02 Warner-Lambert Company Système pour la libération d'un médicament et procédé pour sa préparation
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems

Also Published As

Publication number Publication date
DE1219176B (de) 1966-06-16
BE623704A (fr)
ES281704A1 (es) 1963-04-16
MY6600083A (en) 1966-12-31
FR2172M (fr) 1963-11-25

Similar Documents

Publication Publication Date Title
GB1030127A (en) Improvements in or relating to method of preparing sustained release pharmaceutical pellets and product thereof
ES2251991T3 (es) Composiciones farmaceuticas orales que contienen trigliceridos de cadena larga y tensioactivos lipofilicos.
US6596308B2 (en) Controlled release pharmaceutical composition
US6491950B1 (en) Controlled release pharmaceutical composition
US3082154A (en) Improved free-flowing coated antimalarial salts in particulate form
AU594264B2 (en) Therapeutic agents
PT98879A (pt) Processo para a preparacao de microcapsulas mascaveis esferoidais revestidas
JP2005508301A5 (fr)
GB967610A (en) Sustained release medicament formulations
US3061510A (en) Radioactive iodinated (i131) fatty material admixed with wax-like material in capsule
US5580576A (en) Pharmaceutically/storage-stable nicorandil formulations
US5736542A (en) Pharmaceutical compositions containing a staurosporine
GB1296505A (fr)
CA2323177A1 (fr) Composition
SK283442B6 (sk) Farmaceutický prípravok na orálne podanie
EP0230332A1 (fr) Composition pharmaceutique à effet prolongé du composé actif et procédé de préparation
JP3983339B2 (ja) 活性成分の調節放出のための安定化親油性マトリックスを基本とする医薬組成物
US11690835B2 (en) Formulation
JPH10330250A (ja) メナテトレノン油性製剤
AT232648B (de) Verfahren zur Herstellung einer Arzneimittelzubereitung mit verzögerter Wirkstoff-Freisetzung
US3152045A (en) Composition and method for angina pectoris therapy
JP5852816B2 (ja) 液状医薬組成物、及びこれを含有する軟カプセル剤
US20190247308A1 (en) Stable liquid formulations
JPS56131344A (en) Preparation of foaming fat or oil for cake
EP3257502A1 (fr) Formulations sous forme de capsules pour l'administration systémique par voie orale comprenant de la s-adénosylméthionine et acides gras poly-nonsaturés, leur préparation et leur utilisation